Karen Porter, Ph.D. - Publications

Affiliations: 
2009 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Physiology Biology, Neurobiology Biology

3/182 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Porter K, Hayward LF. Stress-induced changes in c-Fos and corticotropin releasing hormone immunoreactivity in the amygdala of the spontaneously hypertensive rat. Behavioural Brain Research. 216: 543-51. PMID 20832430 DOI: 10.1016/J.Bbr.2010.08.036  0.647
2009 Porter K, Ahlgren J, Stanley J, Hayward LF. Modulation of heart rate variability during severe hemorrhage at different rates in conscious rats. Autonomic Neuroscience : Basic & Clinical. 150: 53-61. PMID 19482559 DOI: 10.1016/J.Autneu.2009.04.009  0.532
2007 Ahlgren J, Porter K, Hayward LF. Hemodynamic responses and c-Fos changes associated with hypotensive hemorrhage: standardizing a protocol for severe hemorrhage in conscious rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 292: R1862-71. PMID 17218446 DOI: 10.1152/Ajpregu.00325.2006  0.537
Low-probability matches (unlikely to be authored by this person)
2006 Porter KL, Shetty G, Meistrich ML. Testicular edema is associated with spermatogonial arrest in irradiated rats. Endocrinology. 147: 1297-305. PMID 16306082 DOI: 10.1210/en.2005-0890  0.273
2003 Meistrich ML, Wilson G, Porter KL, Huhtaniemi I, Shetty G, Shuttlesworth GA. Restoration of spermatogenesis in dibromochloropropane (DBCP)-treated rats by hormone suppression. Toxicological Sciences : An Official Journal of the Society of Toxicology. 76: 418-26. PMID 14514963 DOI: 10.1093/toxsci/kfg237  0.238
2003 Meistrich ML, Wilson G, Shuttlesworth GA, Porter KL. Dibromochloropropane inhibits spermatogonial development in rats. Reproductive Toxicology (Elmsford, N.Y.). 17: 263-71. PMID 12759094  0.233
2009 Porter KL, Shetty G, Shuttlesworth GA, Weng CC, Huhtaniemi I, Pakarinen P, Meistrich ML. Estrogen enhances recovery from radiation-induced spermatogonial arrest in rat testes. Journal of Andrology. 30: 440-51. PMID 19136390 DOI: 10.2164/jandrol.108.006635  0.232
2012 Porter K, Medford HM, McIntosh CM, Marsh SA. Cardioprotection requires flipping the 'posttranslational modification' switch. Life Sciences. 90: 89-98. PMID 22154907 DOI: 10.1016/j.lfs.2011.10.026  0.207
2020 Shawer H, Hemmings K, Porter K, Foster R, Beech DJ, Bailey MA. Abstract 16436: Targeting Store Operated Calcium Entry in Vascular Smooth Muscle Cells by a Novel Small-molecule Inhibitor Circulation. 142. DOI: 10.1161/CIRC.142.SUPPL_3.16436  0.207
2017 MacDougall DA, Pugh SD, Bassi HS, Lotteau S, Porter KE, Calaghan S. Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I. Frontiers in Pharmacology. 8: 203. PMID 28469574 DOI: 10.3389/fphar.2017.00203  0.193
2014 Pugh SD, MacDougall DA, Agarwal SR, Harvey RD, Porter KE, Calaghan S. Caveolin contributes to the modulation of basal and β-adrenoceptor stimulated function of the adult rat ventricular myocyte by simvastatin: a novel pleiotropic effect. Plos One. 9: e106905. PMID 25211146 DOI: 10.1371/journal.pone.0106905  0.191
2011 Porter KE, Turner NA. Statins and myocardial remodelling: cell and molecular pathways. Expert Reviews in Molecular Medicine. 13: e22. PMID 21718586 DOI: 10.1017/S1462399411001931  0.186
2012 Longster AL, MacDougall DA, Porter KE, Calaghan S. In Vivo Simvastatin Treatment Differentially Affects Caveolin-1 and Caveolin-3 Expression in the Adult Rat Myocardium Biophysical Journal. 102: 138a. DOI: 10.1016/J.BPJ.2011.11.763  0.181
1983 Porter KG, Feig YS, Vetter EF. Morphology, flow regimes, and filtering rates of Daphnia, Ceriodaphnia, and Bosmina fed natural bacteria. Oecologia. 58: 156-163. PMID 28310572 DOI: 10.1007/BF00399211  0.18
2009 Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacology & Therapeutics. 123: 255-78. PMID 19460403 DOI: 10.1016/j.pharmthera.2009.05.002  0.173
2018 Bageghni SA, Hemmings KE, Zava N, Denton CP, Porter KE, Ainscough JFX, Drinkhill MJ, Turner NA. Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701455RR. PMID 29601781 DOI: 10.1096/fj.201701455RR  0.166
1984 Orcutt JD, Porter KG. The synergistic effects of temperature and food concentration of life history parameters of Daphnia. Oecologia. 63: 300-306. PMID 28311203 DOI: 10.1007/BF00390657  0.161
2013 Turner NA, Porter KE. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis & Tissue Repair. 6: 5. PMID 23448358 DOI: 10.1186/1755-1536-6-5  0.156
2013 Medford HM, Porter K, Marsh SA. Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology. 305: H114-23. PMID 23624624 DOI: 10.1152/ajpheart.00135.2013  0.153
2012 Clarke NE, Fisher MJ, Porter KE, Lambert DW, Turner AJ. Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. Plos One. 7: e34747. PMID 22523556 DOI: 10.1371/journal.pone.0034747  0.149
2008 Eccles KA, Sowden H, Porter KE, Parkin SM, Homer-Vanniasinkam S, Graham AM. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis. 200: 69-79. PMID 18486135 DOI: 10.1016/j.atherosclerosis.2007.12.018  0.147
2017 Mylonas KJ, Turner NA, Bageghni SA, Kenyon CJ, White CI, McGregor K, Kimmitt RA, Sulston R, Kelly V, Walker BR, Porter KE, Chapman KE, Gray GA. 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI. The Journal of Endocrinology. 233: 315-327. PMID 28522730 DOI: 10.1530/JOE-16-0501  0.145
2016 Kovari DT, Wei W, Chang P, Toro JS, Beach RF, Chambers D, Porter K, Koo D, Curtis JE. Frustrated Phagocytic Spreading of J774A-1 Macrophages Ends in Myosin II-Dependent Contraction. Biophysical Journal. 111: 2698-2710. PMID 28002746 DOI: 10.1016/J.Bpj.2016.11.009  0.145
2014 Sedgwick B, Riches K, Bageghni SA, O'Regan DJ, Porter KE, Turner NA. Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 23: 204-10. PMID 24746387 DOI: 10.1016/j.carpath.2014.03.004  0.143
1995 Varty K, Jones L, Porter KE, Bell PRF, London NJML. A Quantitative Study of Long Saphenous Vein Morphology in Patients Undergoing Arterial Surgery Phlebology: the Journal of Venous Disease. 10: 90-93. DOI: 10.1177/026835559501000302  0.143
2009 Mughal RS, Warburton P, O'Regan DJ, Ball SG, Turner NA, Porter KE. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function. Clinical and Experimental Pharmacology & Physiology. 36: 478-86. PMID 19673929 DOI: 10.1111/j.1440-1681.2008.05088.x  0.141
2014 Cubbon RM, Yuldasheva NY, Viswambharan H, Mercer BN, Baliga V, Stephen SL, Askham J, Sukumar P, Skromna A, Mughal RS, Walker AM, Bruns A, Bailey MA, Galloway S, Imrie H, ... ... Porter KE, et al. Restoring Akt1 activity in outgrowth endothelial cells from South Asian men rescues vascular reparative potential. Stem Cells (Dayton, Ohio). 32: 2714-23. PMID 24916783 DOI: 10.1002/stem.1766  0.139
2012 Sukumar P, Sedo A, Li J, Wilson LA, O'Regan D, Lippiat JD, Porter KE, Kearney MT, Ainscough JF, Beech DJ. Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin. Circulation Research. 111: 191-200. PMID 22668831 DOI: 10.1161/CIRCRESAHA.112.270751  0.137
2012 Rajwani A, Ezzat V, Smith J, Yuldasheva NY, Duncan ER, Gage M, Cubbon RM, Kahn MB, Imrie H, Abbas A, Viswambharan H, Aziz A, Sukumar P, Vidal-Puig A, Sethi JK, ... ... Porter KE, et al. Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes. 61: 915-24. PMID 22357965 DOI: 10.2337/Db11-0963  0.134
2000 White PJ, Kumari R, Porter KE, London NJ, Ng LL, Boarder MR. Antiproliferative effect of UTP on human arterial and venous smooth muscle cells. American Journal of Physiology. Heart and Circulatory Physiology. 279: H2735-42. PMID 11087228 DOI: 10.1152/AJPHEART.2000.279.6.H2735  0.133
2014 Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity. Cardiovascular Revascularization Medicine : Including Molecular Interventions. 15: 141-8. PMID 24642103 DOI: 10.1016/j.carrev.2014.02.005  0.132
2012 Turner NA, Porter KE. Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts. Iubmb Life. 64: 143-50. PMID 22215527 DOI: 10.1002/iub.594  0.131
2007 Turner NA, Ho S, Warburton P, O'Regan DJ, Porter KE. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. Journal of Vascular Surgery. 45: 1022-8. PMID 17466797 DOI: 10.1016/j.jvs.2007.01.061  0.13
2019 Blythe NM, Muraki K, Ludlow MJ, Stylianidis V, Gilbert HTJ, Evans EL, Cuthbertson K, Foster R, Swift J, Li J, Drinkhill MJ, van Nieuwenhoven FA, Porter KE, Beech DJ, Turner NA. Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion. The Journal of Biological Chemistry. PMID 31586031 DOI: 10.1074/Jbc.Ra119.009167  0.13
2016 Barallobre-Barreiro J, Oklu R, Lynch M, Fava M, Baig F, Yin X, Barwari T, Potier DN, Albadawi H, Jahangiri M, Porter KE, Watkins MT, Misra S, Stoughton J, Mayr M. Extracellular Matrix Remodeling in Response to Venous Hypertension: Proteomics of Human Varicose Veins. Cardiovascular Research. PMID 27068509 DOI: 10.1093/cvr/cvw075  0.129
2013 Maqbool A, Hemmings KE, O'Regan DJ, Ball SG, Porter KE, Turner NA. Interleukin-1 has opposing effects on connective tissue growth factor and tenascin-C expression in human cardiac fibroblasts. Matrix Biology : Journal of the International Society For Matrix Biology. 32: 208-14. PMID 23454256 DOI: 10.1016/j.matbio.2013.02.003  0.129
2010 Riches K, Hettiarachchi NT, Porter KE, Peers C. Hypoxic remodelling of Ca2+ stores does not alter human cardiac myofibroblast invasion. Biochemical and Biophysical Research Communications. 403: 468-72. PMID 21094145 DOI: 10.1016/J.Bbrc.2010.11.060  0.123
2011 Porter KL, Olmstead AW, Kumsher DM, Dennis WE, Sprando RL, Holcombe GW, Korte JJ, Lindberg-Livingston A, Degitz SJ. Effects of 4-tert-octylphenol on Xenopus tropicalis in a long term exposure. Aquatic Toxicology (Amsterdam, Netherlands). 103: 159-69. PMID 21470552 DOI: 10.1016/j.aquatox.2011.02.019  0.122
2009 Milligan CJ, Li J, Sukumar P, Majeed Y, Dallas ML, English A, Emery P, Porter KE, Smith AM, McFadzean I, Beccano-Kelly D, Bahnasi Y, Cheong A, Naylor J, Zeng F, et al. Robotic multiwell planar patch-clamp for native and primary mammalian cells. Nature Protocols. 4: 244-55. PMID 19197268 DOI: 10.1038/Nprot.2008.230  0.121
2009 Madi HA, Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. American Journal of Physiology. Cell Physiology. 297: C1307-17. PMID 19741193 DOI: 10.1152/ajpcell.00608.2008  0.121
2009 Aley PK, Bauer CC, Dallas ML, Boyle JP, Porter KE, Peers C. Hypoxic modulation of ca(2+) signaling in human venous and arterial endothelial cells. The Journal of Membrane Biology. 227: 151-8. PMID 19132435 DOI: 10.1007/S00232-008-9147-Z  0.115
2013 Riches K, Franklin L, Maqbool A, Peckham M, Adams M, Bond J, Warburton P, Feric NT, Koschinsky ML, O'Regan DJ, Ball SG, Turner NA, Porter KE. Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms. The International Journal of Biochemistry & Cell Biology. 45: 1776-83. PMID 23726972 DOI: 10.1016/j.biocel.2013.05.021  0.115
2011 Turner NA, Das A, O'Regan DJ, Ball SG, Porter KE. Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation. The International Journal of Biochemistry & Cell Biology. 43: 1450-8. PMID 21718796 DOI: 10.1016/j.biocel.2011.06.008  0.114
2010 Cubbon RM, Murgatroyd SR, Ferguson C, Bowen TS, Rakobowchuk M, Baliga V, Cannon D, Rajwani A, Abbas A, Kahn M, Birch KM, Porter KE, Wheatcroft SB, Rossiter HB, Kearney MT. 020 Human exercise induced circulating progenitor cell mobilisation is nitric oxide dependent and is blunted in South Asian men Heart. 96. DOI: 10.1136/Hrt.2010.195941.20  0.114
2015 Roberts AC, Gohil J, Hudson L, Connolly K, Warburton P, Suman R, O'Toole P, O'Regan DJ, Turner NA, Riches K, Porter KE. Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure? Journal of Diabetes Research. 2015: 409432. PMID 25950006 DOI: 10.1155/2015/409432  0.112
2008 Guy JL, Lambert DW, Turner AJ, Porter KE. Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts. Experimental Physiology. 93: 579-88. PMID 18223028 DOI: 10.1113/expphysiol.2007.040139  0.111
1995 Newman CM, Bruun BC, Porter KE, Mistry PK, Shanahan CM, Weissberg PL. Osteopontin is not a marker for proliferating human vascular smooth muscle cells Arteriosclerosis, Thrombosis, and Vascular Biology. 15: 2010-2018. PMID 7583583 DOI: 10.1161/01.ATV.15.11.2010  0.111
2013 Porter KE, Riches K. The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes? Clinical Science (London, England : 1979). 125: 167-82. PMID 23634936 DOI: 10.1042/CS20120413  0.111
2012 Riches K, Porter KE. Lipoprotein(a): Cellular Effects and Molecular Mechanisms. Cholesterol. 2012: 923289. PMID 22991657 DOI: 10.1155/2012/923289  0.11
2018 Alshanwani AR, Riches-Suman K, O'Regan DJ, Wood IC, Turner NA, Porter KE. MicroRNA-21 drives the switch to a synthetic phenotype in human saphenous vein smooth muscle cells. Iubmb Life. PMID 29659130 DOI: 10.1002/iub.1751  0.11
1984 Pace ML, Porter K, Feig YS. Life history variation within a parthenogenetic population of Daphnia parvula (Crustacea: Cladocera). Oecologia. 63: 43-51. PMID 28311164 DOI: 10.1007/Bf00379783  0.108
2007 Knechtges PL, Sprando RL, Porter KL, Brennan LM, Miller MF, Kumsher DM, Dennis WE, Brown CC, Clegg ED. A novel amphibian tier 2 testing protocol: a 30-week exposure of Xenopus tropicalis to the antiandrogen flutamide. Environmental Toxicology and Chemistry / Setac. 26: 555-64. PMID 17373522 DOI: 10.1897/06-210R.1  0.106
2006 Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P, Naylor J, Forte A, Cipollaro M, McHugh D, Kingston PA, Heagerty AM, Munsch CM, Bergdahl A, HultgÃ¥rdh-Nilsson A, ... ... Porter KE, et al. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circulation Research. 98: 557-63. PMID 16439693 DOI: 10.1161/01.RES.0000204724.29685.db  0.106
2012 Nintasen R, Riches K, Mughal RS, Viriyavejakul P, Chaisri U, Maneerat Y, Turner NA, Porter KE. Divergent effects of 17-β-estradiol on human vascular smooth muscle and endothelial cell function diminishes TNF-α-induced neointima formation. Biochemical and Biophysical Research Communications. 420: 828-33. PMID 22465119 DOI: 10.1016/j.bbrc.2012.03.082  0.105
2007 Morley ME, Riches K, Peers C, Porter KE. Hypoxic inhibition of human cardiac fibroblast invasion and MMP-2 activation may impair adaptive myocardial remodelling. Biochemical Society Transactions. 35: 905-7. PMID 17956242 DOI: 10.1042/Bst0350905  0.105
2021 Hemmings KE, Riches-Suman K, Bailey MA, O'Regan DJ, Turner NA, Porter KE. Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic Patients. Cells. 10. PMID 33923614 DOI: 10.3390/cells10040919  0.104
2000 Peterson M, Porter KE, Loftus IM, Thompson MM, London NJ. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 19: 461-7. PMID 10828225 DOI: 10.1053/ejvs.1999.1041  0.101
2010 Cubbon RM, Murgatroyd SR, Ferguson C, Bowen TS, Rakobowchuk M, Baliga V, Cannon D, Rajwani A, Abbas A, Kahn M, Birch KM, Porter KE, Wheatcroft SB, Rossiter HB, Kearney MT. Human exercise-induced circulating progenitor cell mobilization is nitric oxide-dependent and is blunted in South Asian men. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 878-84. PMID 20110574 DOI: 10.1161/Atvbaha.109.201012  0.1
1998 Porter KE, Olojugba DH, Masood I, Pemberton M, Bell PR, London NJ. Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein. Journal of Vascular Surgery. 28: 695-701. PMID 9786266 DOI: 10.1016/S0741-5214(98)70096-5  0.1
1989 Tranvik LJ, Porter KG, Sieburth JM. Occurrence of bacterivory in Cryptomonas, a common freshwater phytoplankter. Oecologia. 78: 473-476. PMID 28312175 DOI: 10.1007/BF00378736  0.099
2013 Roberts AC, Porter KE. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diabetes & Vascular Disease Research. 10: 472-82. PMID 24002671 DOI: 10.1177/1479164113500680  0.099
2006 Peers C, Aley PK, Boyle JP, Porter KE, Pearson HA, Smith IF, Kemp PJ. Hypoxic regulation of Ca2+ signalling in astrocytes and endothelial cells. Advances in Experimental Medicine and Biology. 580: 185-90; discussion 3. PMID 16683717 DOI: 10.1007/0-387-31311-7_28  0.098
2016 Tumova S, Kerimi A, Porter KE, Williamson G. Transendothelial glucose transport is not restricted by extracellular hyperglycaemia. Vascular Pharmacology. PMID 27825869 DOI: 10.1016/j.vph.2016.11.001  0.098
2006 Barnett MW, Watson RF, Vitalis T, Porter K, Komiyama NH, Stoney PN, Gillingwater TH, Grant SG, Kind PC. Synaptic Ras GTPase activating protein regulates pattern formation in the trigeminal system of mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1355-65. PMID 16452659 DOI: 10.1523/Jneurosci.3164-05.2006  0.098
2006 Peers C, Kang P, Boyle JP, Porter KE, Pearson HA, Smith IF, Kemp PJ. Hypoxic regulation of Ca2+ signalling in astrocytes and endothelial cells. Novartis Foundation Symposium. 272: 119-27; discussion 1. PMID 16686433 DOI: 10.1002/9780470035009.ch10  0.098
2019 Bageghni SA, Hemmings KE, Yuldasheva NY, Maqbool A, Gamboa-Esteves FO, Humphreys NE, Simonsen Jackson M, Denton CP, Francis S, Porter KE, Ainscough JFX, Pinteaux E, Drinkhill MJ, Turner NA. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. Jci Insight. 5. PMID 31393855 DOI: 10.1172/Jci.Insight.125074  0.097
2002 Arun C, Swift B, Porter K, West K, London N, Hemingway D. The Role of Big Endothelin-1 in Colorectal Cancer The International Journal of Biological Markers. 17: 268-274. DOI: 10.1177/172460080201700407  0.097
2020 Tsai YM, Jones F, Mullen P, Porter KE, Steele D, Peers C, Gamper N. Vascular Kv7 channels control intracellular Ca dynamics in smooth muscle. Cell Calcium. 92: 102283. PMID 32950876 DOI: 10.1016/J.Ceca.2020.102283  0.096
2011 Li J, McKeown L, Ojelabi O, Stacey M, Foster R, O'Regan D, Porter KE, Beech DJ. Nanomolar potency and selectivity of a Ca²⁺ release-activated Ca²⁺ channel inhibitor against store-operated Ca²⁺ entry and migration of vascular smooth muscle cells. British Journal of Pharmacology. 164: 382-93. PMID 21545575 DOI: 10.1111/j.1476-5381.2011.01368.x  0.094
2004 Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovascular Research. 61: 745-55. PMID 14985071 DOI: 10.1016/j.cardiores.2003.11.032  0.094
2019 Lyall GK, Davies MJ, Ferguson C, Porter KE, Birch KM. In-exercise vascular shear rate during acute continuous and interval exercise: impact upon endothelial function and MiR-21. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 31600098 DOI: 10.1152/japplphysiol.00156.2019  0.092
2007 Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, Midgley L, O'Regan DJ, Wood IC, Ball SG, Porter KE. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. Journal of Molecular and Cellular Cardiology. 43: 168-76. PMID 17560598 DOI: 10.1016/j.yjmcc.2007.05.006  0.092
2011 Dedman AM, Majeed Y, Tumova S, Zeng F, Kumar B, Munsch C, Bateson AN, Wittmann J, Jäck HM, Porter KE, Beech DJ. TRPC1 transcript variants, inefficient nonsense-mediated decay and low up-frameshift-1 in vascular smooth muscle cells. Bmc Molecular Biology. 12: 30. PMID 21749700 DOI: 10.1186/1471-2199-12-30  0.092
1996 Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJM. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia Cardiovascular Research. 31: 607-614. PMID 8689653 DOI: 10.1016/0008-6363(95)00230-8  0.09
2017 Riches K, Clark E, Helliwell RJ, Angelini TG, Hemmings KE, Bailey MA, Bridge KI, Scott DJA, Porter KE. Progressive Development of Aberrant Smooth Muscle Cell Phenotype in Abdominal Aortic Aneurysm Disease. Journal of Vascular Research. 55: 35-46. PMID 29232676 DOI: 10.1159/000484088  0.089
2012 Majeed Y, Tumova S, Green BL, Seymour VA, Woods DM, Agarwal AK, Naylor J, Jiang S, Picton HM, Porter KE, O'Regan DJ, Muraki K, Fishwick CW, Beech DJ. Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone. Cell Calcium. 51: 1-11. PMID 22000496 DOI: 10.1016/J.Ceca.2011.09.005  0.089
2015 Li J, Bruns AF, Hou B, Rode B, Webster PJ, Bailey MA, Appleby HL, Moss NK, Ritchie JE, Yuldasheva NY, Tumova S, Quinney M, McKeown L, Taylor H, Prasad KR, ... ... Porter KE, et al. Orai3 Surface Accumulation and Calcium Entry Evoked by Vascular Endothelial Growth Factor. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 1987-94. PMID 26160956 DOI: 10.1161/ATVBAHA.115.305969  0.089
2015 Porter KE, Riches K. Vascular Smooth Muscle as a Target for Novel Therapeutics. Current Diabetes Reports. 15: 72. PMID 26277484 DOI: 10.1007/s11892-015-0647-9  0.088
2007 Turner NA, Midgley L, O'Regan DJ, Porter KE. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. Journal of Cardiovascular Pharmacology. 50: 458-61. PMID 18049315 DOI: 10.1097/FJC.0b013e318123767f  0.087
1998 Porter KE, Loftus IM, Peterson M, Bell PR, London NJ, Thompson MM. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis. The British Journal of Surgery. 85: 1373-7. PMID 9782017 DOI: 10.1046/j.1365-2168.1998.00888.x  0.087
2004 Siegert RJ, Lord S, Porter K. Constraint-induced movement therapy: time for a little restraint? Clinical Rehabilitation. 18: 110-4. PMID 14763726  0.087
2010 Naylor J, Li J, Milligan CJ, Zeng F, Sukumar P, Hou B, Sedo A, Yuldasheva N, Majeed Y, Beri D, Jiang S, Seymour VA, McKeown L, Kumar B, Harteneck C, ... ... Porter KE, et al. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. Circulation Research. 106: 1507-15. PMID 20360246 DOI: 10.1161/CIRCRESAHA.110.219329  0.087
2010 Bauer CC, Boyle JP, Porter KE, Peers C. Modulation of Ca(2+) signalling in human vascular endothelial cells by hydrogen sulfide. Atherosclerosis. 209: 374-80. PMID 19875115 DOI: 10.1016/J.Atherosclerosis.2009.10.004  0.086
2016 Maqbool A, Spary EJ, Manfield IW, Ruhmann M, Zuliani-Alvarez L, Gamboa-Esteves FO, Porter KE, Drinkhill MJ, Midwood KS, Turner NA. Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4. World Journal of Cardiology. 8: 340-50. PMID 27231521 DOI: 10.4330/wjc.v8.i5.340  0.084
2010 Al-Shawaf E, Naylor J, Taylor H, Riches K, Milligan CJ, O'Regan D, Porter KE, Li J, Beech DJ. Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1453-9. PMID 20378846 DOI: 10.1161/ATVBAHA.110.205666  0.084
2005 Aley PK, Porter KE, Boyle JP, Kemp PJ, Peers C. Hypoxic modulation of Ca2+ signaling in human venous endothelial cells. Multiple roles for reactive oxygen species. The Journal of Biological Chemistry. 280: 13349-54. PMID 15668229 DOI: 10.1074/jbc.M413674200  0.084
2005 Porter K, Komiyama NH, Vitalis T, Kind PC, Grant SG. Differential expression of two NMDA receptor interacting proteins, PSD-95 and SynGAP during mouse development. The European Journal of Neuroscience. 21: 351-62. PMID 15673435 DOI: 10.1111/J.1460-9568.2005.03874.X  0.083
2015 Duckles H, Boycott HE, Al-Owais MM, Elies J, Johnson E, Dallas ML, Porter KE, Giuntini F, Boyle JP, Scragg JL, Peers C. Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels. PflüGers Archiv : European Journal of Physiology. 467: 415-27. PMID 24744106 DOI: 10.1007/S00424-014-1503-5  0.083
2004 Porter KE, Turner NA, O'Regan DJ, Ball SG. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovascular Research. 64: 507-15. PMID 15537504 DOI: 10.1016/j.cardiores.2004.07.020  0.083
2008 Aley PK, Wilkinson JA, Bauer CC, Boyle JP, Porter KE, Peers C. Hypoxic remodelling of Ca(2+) signalling in proliferating human arterial smooth muscle. Molecular and Cellular Biochemistry. 318: 101-8. PMID 18636316 DOI: 10.1007/S11010-008-9861-Y  0.083
1996 Varty K, Porter K, Bell PR, London NJ. Vein morphology and bypass graft stenosis. The British Journal of Surgery. 83: 1375-9. PMID 8944432 DOI: 10.1002/BJS.1800831015  0.081
2011 Shetty G, Porter KL, Zhou W, Shao SH, Weng CC, Meistrich ML. Androgen suppression-induced stimulation of spermatogonial differentiation in juvenile spermatogonial depletion mice acts by elevating the testicular temperature. Endocrinology. 152: 3504-14. PMID 21733828 DOI: 10.1210/en.2011-0251  0.081
2013 Riches K, Angelini TG, Mudhar GS, Kaye J, Clark E, Bailey MA, Sohrabi S, Korossis S, Walker PG, Scott DJ, Porter KE. Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm. Journal of Translational Medicine. 11: 208. PMID 24028184 DOI: 10.1186/1479-5876-11-208  0.081
2005 Corpataux JM, Naik J, Porter KE, London NJ. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells. The Journal of Surgical Research. 129: 52-6. PMID 16087194 DOI: 10.1016/j.jss.2005.05.016  0.081
2006 Morley ME, Turner NA, Peers C, Porter KE. The effect of hypoxia on collagen stimulated MMP-2 activation in human cardiac fibroblasts Journal of Molecular and Cellular Cardiology. 40: 936. DOI: 10.1016/J.Yjmcc.2006.03.059  0.081
2014 Riches K, Alshanwani AR, Warburton P, O'Regan DJ, Ball SG, Wood IC, Turner NA, Porter KE. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. Journal of Molecular and Cellular Cardiology. 74: 240-50. PMID 24927876 DOI: 10.1016/j.yjmcc.2014.05.018  0.08
1996 Porter KE, Varty K, Jones L, Bell PRF, London NJM. Human saphenous vein organ culture: A useful model of intimal hyperplasia? European Journal of Vascular and Endovascular Surgery. 11: 48-58. PMID 8564487 DOI: 10.1016/S1078-5884(96)80134-1  0.08
2021 Styles FL, Al-Owais MM, Scragg JL, Chuntharpursat-Bon E, Hettiarachchi NT, Lippiat JD, Minard A, Bon RS, Porter K, Sukumar P, Peers C, Roberts LD. Kv1.3 voltage-gated potassium channels link cellular respiration to proliferation through a non-conducting mechanism. Cell Death & Disease. 12: 372. PMID 33828089 DOI: 10.1038/s41419-021-03627-6  0.079
2008 Li J, Sukumar P, Milligan CJ, Kumar B, Ma ZY, Munsch CM, Jiang LH, Porter KE, Beech DJ. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circulation Research. 103: e97-104. PMID 18802022 DOI: 10.1161/Circresaha.108.182931  0.079
2005 Turner NA, O'Regan DJ, Ball SG, Porter KE. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 804-6. PMID 15728660 DOI: 10.1096/fj.04-2852fje  0.077
2006 Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, Shah S, Dedman AM, Flemming PK, McHugh D, Naylor J, Cheong A, Bateson AN, Munsch CM, Porter KE, Beech DJ. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circulation Research. 98: 1381-9. PMID 16675717 DOI: 10.1161/01.RES.0000225284.36490.a2  0.077
2010 Turner NA, Warburton P, Porter KE. BAS/BSCR41 Modulation of extracellular matrix protein expression by interleukin 1 in human cardiac myofibroblasts: regulation by p38 MAP kinase Heart. 96: e24-e25. DOI: 10.1136/hrt.2010.205781.52  0.076
2022 Lyall GK, Birk GK, Harris E, Ferguson C, Riches-Suman K, Kearney MT, Porter KE, Birch KM. Efficacy of interval exercise training to improve vascular health in sedentary postmenopausal females. Physiological Reports. 10: e15441. PMID 35986498 DOI: 10.14814/phy2.15441  0.076
2003 Turner NA, Porter KE, Smith WH, White HL, Ball SG, Balmforth AJ. Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovascular Research. 57: 784-92. PMID 12618240 DOI: 10.1016/S0008-6363(02)00729-0  0.076
2009 Maqbool A, Turner NA, Galloway S, Riches K, O'Regan DJ, Porter KE. The -1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients. Atherosclerosis. 207: 458-65. PMID 19541314 DOI: 10.1016/j.atherosclerosis.2009.05.028  0.076
2014 Lambert DW, Lambert LA, Clarke NE, Hooper NM, Porter KE, Turner AJ. Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421. Clinical Science (London, England : 1979). 127: 243-9. PMID 24564768 DOI: 10.1042/CS20130420  0.075
2004 Turner NA, O'regan DJ, Ball SG, Porter KE. Endothelin-1 is an essential co-factor for beta2-adrenergic receptor-induced proliferation of human cardiac fibroblasts. Febs Letters. 576: 156-60. PMID 15474029 DOI: 10.1016/j.febslet.2004.08.080  0.075
2013 van Nieuwenhoven FA, Hemmings KE, Porter KE, Turner NA. Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function. Matrix Biology : Journal of the International Society For Matrix Biology. 32: 399-406. PMID 23583823 DOI: 10.1016/j.matbio.2013.03.008  0.075
2015 Duckles H, Al-Owais MM, Elies J, Johnson E, Boycott HE, Dallas ML, Porter KE, Boyle JP, Scragg JL, Peers C. T-Type Ca(2+) Channel Regulation by CO: A Mechanism for Control of Cell Proliferation. Advances in Experimental Medicine and Biology. 860: 291-300. PMID 26303493 DOI: 10.1007/978-3-319-18440-1_33  0.075
2012 Maqbool A, Keswani A, Galloway S, O'Regan DJ, Ball SG, Turner NA, Porter KE. MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion. The Journal of Surgical Research. 175: 343-9. PMID 21601886 DOI: 10.1016/j.jss.2011.03.043  0.074
2013 Sinfield JK, Das A, O'Regan DJ, Ball SG, Porter KE, Turner NA. p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts. Biochemical and Biophysical Research Communications. 430: 419-24. PMID 23206705 DOI: 10.1016/j.bbrc.2012.11.071  0.074
2002 Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJ, O'Carroll CM, Martin SJ, Morris RG, O'Dell TJ, Grant SG. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9721-32. PMID 12427827 DOI: 10.1523/Jneurosci.22-22-09721.2002  0.073
2019 Smith AJ, Wright KE, Muench SP, Schumann S, Whitehouse A, Porter KE, Colyer J. Styrene maleic acid recovers proteins from mammalian cells and tissues while avoiding significant cell death. Scientific Reports. 9: 16408. PMID 31767876 DOI: 10.1038/s41598-019-51896-1  0.072
2007 Turner NA, Mughal RS, Warburton P, O'Regan DJ, Ball SG, Porter KE. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovascular Research. 76: 81-90. PMID 17612514 DOI: 10.1016/j.cardiores.2007.06.003  0.072
2012 Nanka O, Krejci E, Pesevski Z, Sedmera D, Smart N, Rossdeutsch A, Dube KN, Riegler J, Price AN, Taylor A, Muthurangu V, Turner M, Lythgoe MF, Riley PR, Kryvorot S, ... ... Porter KE, et al. Poster session 3 Cardiovascular Research. 93: S92-S127. DOI: 10.1093/Cvr/Cvr336  0.072
2002 Porter KE, Turner NA. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9 Biochemical Society Transactions. 30: 120-126. DOI: 10.1042/BST0300120  0.071
2021 Viswambharan H, Yuldasheva NY, Imrie H, Bridge K, Haywood NJ, Skromna A, Hemmings KE, Clark ER, Gatenby VK, Cordell P, Simmons K, Makava N, Abudushalamu Y, Endesh N, Brown J, ... ... Porter KE, et al. Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat. Circulation Research. PMID 34420367 DOI: 10.1161/CIRCRESAHA.121.319517  0.071
2002 Porter KL, Chanda S, Wang HQ, Gaido KW, Smart RC, Robinette CL. 17beta-estradiol is a hormonal regulator of mirex tumor promotion sensitivity in mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 69: 42-8. PMID 12215659 DOI: 10.1093/Toxsci/69.1.42  0.071
2012 Maqbool A, Hemmings KE, Porter KE, Turner NA. EFFECTS OF PROINFLAMMATORY CYTOKINES ON MATRICELLULAR PROTEIN EXPRESSION IN HUMAN CARDIAC FIBROBLASTS Heart. 98: A7.1-A7. DOI: 10.1136/heartjnl-2012-303148a.20  0.07
2003 PORTER K. 3551 Simvastatin inhibits human cardiac fibroblast proliferation: implications for prevention of adverse myocardial remodelling European Heart Journal. 24: 689. DOI: 10.1016/S0195-668X(03)96149-5  0.07
2020 Maqbool A, Watt N, Haywood N, Viswambharan H, Skromna A, Makava N, Visnagri A, Shawer HM, Bridge K, Muminov SK, Griffin K, Beech DJ, Wheatcroft SB, Porter KE, Simmons KJ, et al. Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance related vascular damage. American Journal of Physiology. Cell Physiology. PMID 32401607 DOI: 10.1152/ajpcell.00389.2019  0.069
2017 Amir A, Haywood NJ, Cordell PA, Smith J, Yuldasheva NY, Sengupta A, Ali N, Mercer BN, Mughal RS, Riches K, Cubbon RM, Porter KE, Kearney MT, Wheatcroft SB. Insulin-like growth factor binding protein-1 improves vascular endothelial repair in male mice in the setting of insulin resistance. Endocrinology. PMID 29186427 DOI: 10.1210/en.2017-00572  0.069
2008 Xu SZ, Sukumar P, Zeng F, Li J, Jairaman A, English A, Naylor J, Ciurtin C, Majeed Y, Milligan CJ, Bahnasi YM, Al-Shawaf E, Porter KE, Jiang LH, Emery P, et al. TRPC channel activation by extracellular thioredoxin. Nature. 451: 69-72. PMID 18172497 DOI: 10.1038/nature06414  0.068
2005 Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C, Buckley NJ, Neylon CB, Porter KE, Beech DJ, Wood IC. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Molecular Cell. 20: 45-52. PMID 16209944 DOI: 10.1016/j.molcel.2005.08.030  0.067
2011 Naylor J, Al-Shawaf E, McKeown L, Manna PT, Porter KE, O'Regan D, Muraki K, Beech DJ. TRPC5 channel sensitivities to antioxidants and hydroxylated stilbenes. The Journal of Biological Chemistry. 286: 5078-86. PMID 21127073 DOI: 10.1074/jbc.M110.196956  0.067
2014 Hemmings K, Bageghni S, Porter K, Drinkhill M, Ainscough J, Turner N. A TRANSGENIC APPROACH TO STUDY THE EFFECT OF CARDIAC FIBROBLAST-SPECIFIC ABLATION OF IL-1 SIGNALLING ON MYOCARDIAL REMODELLING Heart. 100: A19.3-A20. DOI: 10.1136/HEARTJNL-2014-306916.58  0.067
2022 Clark ER, Helliwell RJ, Bailey MA, Hemmings KE, Bridge KI, Griffin KJ, Scott DJA, Jennings LM, Riches-Suman K, Porter KE. Preservation of Smooth Muscle Cell Integrity and Function: A Target for Limiting Abdominal Aortic Aneurysm Expansion? Cells. 11. PMID 35326494 DOI: 10.3390/cells11061043  0.066
2002 Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, London NJ. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. Journal of Vascular Surgery. 36: 150-7. PMID 12096273 DOI: 10.1067/mva.2002.122029  0.065
2009 Riches K, Morley ME, Turner NA, O'Regan DJ, Ball SG, Peers C, Porter KE. Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. Journal of Molecular and Cellular Cardiology. 47: 391-9. PMID 19523958 DOI: 10.1016/J.Yjmcc.2009.06.002  0.064
2010 Pugh SD, Porter KE, Calaghan S. A Novel Pleiotropic Effect of Statins: Enhanced Cardiomyocyte β2-Adrenoceptor Responsiveness Biophysical Journal. 98: 721a. DOI: 10.1016/J.BPJ.2009.12.3947  0.063
2010 Turner NA, Warburton P, O'Regan DJ, Ball SG, Porter KE. Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase. Matrix Biology : Journal of the International Society For Matrix Biology. 29: 613-20. PMID 20619343 DOI: 10.1016/j.matbio.2010.06.007  0.062
2013 Mercer B, Yuldasheva N, Viswambharan H, Baliga V, Stephen S, Askham J, Sukumar P, Skromna A, Mughal R, Imrie H, Gage M, Rakobowchuk M, Li J, Porter K, Ponnambalam S, et al. 201 RESTORING AKT ACTIVITY IN LATE OUTGROWTH ENDOTHELIAL PROGENITOR CELLS FROM HUMANS AT HIGH CARDIOVASCULAR RISK RESCUES THEIR ANGIOGENIC CAPACITY Heart. 99: A111.1-A111. DOI: 10.1136/heartjnl-2013-304019.201  0.062
2002 Arun C, Swift B, Porter KE, West KP, London NJ, Hemingway DM. The role of big endothelin-1 in colorectal cancer. The International Journal of Biological Markers. 17: 268-74. PMID 12521131 DOI: 10.5301/JBM.2008.3267  0.062
2012 McKeown L, Moss NK, Turner P, Li J, Heath N, Burke D, O'Regan D, Gilthorpe MS, Porter KE, Beech DJ. Platelet-derived growth factor maintains stored calcium through a nonclustering Orai1 mechanism but evokes clustering if the endoplasmic reticulum is stressed by store depletion. Circulation Research. 111: 66-76. PMID 22556336 DOI: 10.1161/CIRCRESAHA.111.263616  0.059
2010 Sinfield JK, Das A, Porter KE, Turner NA. BAS/BSCR42 Effect of p38-  gene silencing on cytokine and matrix metalloproteinase expression by human cardiac myofibroblasts Heart. 96: e25-e25. DOI: 10.1136/hrt.2010.205781.53  0.059
2011 Cheong A, Li J, Sukumar P, Kumar B, Zeng F, Riches K, Munsch C, Wood IC, Porter KE, Beech DJ. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovascular Research. 89: 282-9. PMID 20884640 DOI: 10.1093/cvr/cvq305  0.058
2010 Riches K, Franklin L, Chowdhury R, Maqbool A, O'Regan DJ, Ball SG, Koschinsky ML, Turner NA, Porter KE. BAS/BSCR29 Apolipoprotein(a) impairs adaptive remodelling in human saphenous vein endothelial and smooth muscle cells Heart. 96: e20-e20. DOI: 10.1136/hrt.2010.205781.40  0.058
2008 Riches K, Morley ME, Peers C, Porter KE. Hypoxic inhibition of MMP-2 activation and invasion in human cardiac myofibroblasts Journal of Molecular and Cellular Cardiology. 44: 737-738. DOI: 10.1016/J.Yjmcc.2008.02.065  0.058
2009 Amer MS, Li J, O'Regan DJ, Steele DS, Porter KE, Sivaprasadarao A, Beech DJ. Translocon closure to Ca2+ leak in proliferating vascular smooth muscle cells. American Journal of Physiology. Heart and Circulatory Physiology. 296: H910-6. PMID 19218505 DOI: 10.1152/Ajpheart.00984.2008  0.057
2010 Mughal RS, Scragg JL, Lister P, Warburton P, Riches K, O'Regan DJ, Ball SG, Turner NA, Porter KE. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia. 53: 1761-71. PMID 20461358 DOI: 10.1007/s00125-010-1736-6  0.057
2012 Cubbon RM, Viswambharan H, Baliga V, Yuldasheva N, Stephen S, Askham J, Mercer BN, Rakobowchuk MR, Sukumar P, Skromna A, Li J, Ponnambalam S, Porter KE, Wheatcroft SB, Beech DJ, et al. A Gene-based restoration of Akt activity in endothelial progenitor cells from human subjects at high cardiovascular risk rescues vascular reparative capacity Heart. 98: A1.1-A1. DOI: 10.1136/heartjnl-2012-301877a.1  0.056
2022 Porter K, Burch N, Campbell C, Danbury C, Foster C, Gabe S, Goddard A, Harp K, Holdoway A, Hughes T, Ball KL, Nightingale J, Rochford A, Keene AR, Smith A, et al. Supporting people who have eating and drinking difficulties. Clinical Medicine (London, England). 21: e344-e350. PMID 35192476 DOI: 10.7861/clinmed.2021-0161  0.056
2002 Turner N, Porter K, Smith W, White H, Balmforth A. β2-Adrenergic receptor-induced proliferation of human cardiac fibroblasts Biochemical Society Transactions. 30: A42-A42. DOI: 10.1042/BST030A042B  0.055
1999 Porter KE, Thompson MM, Loftus IM, McDermott E, Jones L, Crowther M, Bell PR, London NJ. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 17: 404-12. PMID 10329524 DOI: 10.1053/ejvs.1998.0761  0.055
2008 Turner NA, Sinfield JK, Porter KE. TNFα and IL-1 induce IL-6 expression in human cardiac fibroblasts: Role of p38 MAP kinase subtypes Journal of Molecular and Cellular Cardiology. 44: 714. DOI: 10.1016/J.YJMCC.2008.02.009  0.054
2005 Corpataux JM, Naik J, Porter KE, London NJ. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 29: 177-81. PMID 15649726 DOI: 10.1016/j.ejvs.2004.11.003  0.054
2017 Riches K, Huntriss J, Keeble C, Wood IC, O'Regan DJ, Turner NA, Porter KE. Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes. Diabetes & Vascular Disease Research. 14: 122-129. PMID 28185533 DOI: 10.1177/1479164116677968  0.054
2002 Goodall S, Porter KE, Bell PR, Thompson MM. Enhanced invasive properties exhibited by smooth muscle cells are associated with elevated production of MMP-2 in patients with aortic aneurysms. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 24: 72-80. PMID 12127852 DOI: 10.1053/ejvs.2002.1675  0.054
1997 Masood I, Porter KE, London NJM. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein British Journal of Surgery. 84: 499-503. DOI: 10.1046/J.1365-2168.1997.02597.X  0.052
2006 Shetty G, Weng CC, Porter KL, Zhang Z, Pakarinen P, Kumar TR, Meistrich ML. Spermatogonial differentiation in juvenile spermatogonial depletion (jsd) mice with androgen receptor or follicle-stimulating hormone mutations. Endocrinology. 147: 3563-70. PMID 16627582 DOI: 10.1210/en.2006-0159  0.052
2011 Li J, Cubbon RM, Wilson LA, Amer MS, McKeown L, Hou B, Majeed Y, Tumova S, Seymour VA, Taylor H, Stacey M, O'Regan D, Foster R, Porter KE, Kearney MT, et al. Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation. Circulation Research. 108: 1190-8. PMID 21441136 DOI: 10.1161/CIRCRESAHA.111.243352  0.051
1996 Masood I, Porter KE, London NJM, Pringle JH. Endothelin-1 expression in vein graft stenosis [1] Journal of Vascular Surgery. 24: 901-902. PMID 8918341 DOI: 10.1016/S0741-5214(96)70030-7  0.051
2009 Turner NA, Das A, Warburton P, O'Regan DJ, Ball SG, Porter KE. Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1117-27. PMID 19648252 DOI: 10.1152/ajpheart.00372.2009  0.05
1996 Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJ. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia Cardiovascular Research. 31: 607-614. DOI: 10.1016/S0008-6363(95)00230-8  0.048
2015 Duckles H, Al-Owais MM, Elies J, Johnson E, Boycott HE, Dallas ML, Porter KE, Boyle JP, Scragg JL, Peers C. T-type Ca2+ channel regulation by CO: A mechanism for control of cell proliferation Advances in Experimental Medicine and Biology. 860: 291-300. DOI: 10.1007/978-3-319-18440-1_33  0.047
2007 Cheong A, Sukumar P, Kumar B, Li J, Bingham AJ, Zeng F, Munsch C, Porter KE, Wood IC, Beech DJ. Blockers of K V 1.3 channel suppress smooth muscle response to injury and neointimal hyperplasia The Faseb Journal. 21. DOI: 10.1096/FASEBJ.21.5.A69-C  0.046
1998 Dunlop P, Porter K, Varty K, Bell P, London N. Effect of recombinant growth factors on human saphenous vein smooth muscle cells. In Vitro Cellular & Developmental Biology. Animal. 34: 431-3. PMID 9661041 DOI: 10.1007/s11626-998-0071-4  0.046
2014 Alshanwani A, Riches K, Wood I, Turner N, Porter K. 168 Exploring the Role of Microrna-21 On Human Saphenous Vein Smooth Muscle Cell Function Heart. 100: A96.1-A96. DOI: 10.1136/heartjnl-2014-306118.168  0.044
1999 Loftus IM, Porter K, Peterson M, Boyle J, London NJ, Bell PR, Thompson MM. MMP inhibition reduces intimal hyperplasia in a human vein graft stenosis model. Annals of the New York Academy of Sciences. 878: 547-50. PMID 10415769 DOI: 10.1111/j.1749-6632.1999.tb07723.x  0.044
2020 Clark ER, Hemmings K, Greco S, Neville A, Porter KE, Bryant MG. Tribological Characteristics of Human Vascular Smooth Muscle Cells: The Implication of Disease State on Friction Biotribology. 22: 100122. DOI: 10.1016/j.biotri.2020.100122  0.043
2000 Simpson RA, Dickinson T, Porter KE, London NJ, Hemingway DM. Raised levels of plasma big endothelin 1 in patients with colorectal cancer. The British Journal of Surgery. 87: 1409-13. PMID 11044168 DOI: 10.1046/j.1365-2168.2000.01536.x  0.042
2019 Thompson S, Ranta A, Porter K, Bondi N. How much rehabilitation are our patients with stroke receiving? The New Zealand Medical Journal. 132: 49-55. PMID 31352474  0.04
2007 Turner NA, Hall KT, Ball SG, Porter KE. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis. 193: 36-43. PMID 16979647 DOI: 10.1016/j.atherosclerosis.2006.08.017  0.04
2008 Naylor J, Li J, Milligan CJ, Zeng F, Porter KE, Beech DJ. TRPM3 channel expression and block in vascular smooth muscle cells The Faseb Journal. 22. DOI: 10.1096/FASEBJ.22.1_SUPPLEMENT.937.6  0.04
2001 Porter KE, Dickinson T, London NJ. Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition. Journal of Vascular Surgery. 34: 548-54. PMID 11533610 DOI: 10.1067/mva.2001.115960  0.039
2002 Porter KE. Use of in vitro organ cultures of human saphenous vein as a model for intimal proliferation. Methods in Molecular Biology (Clifton, N.J.). 206: 199-214. PMID 12152228 DOI: 10.1385/1-59259-289-9:199  0.038
2014 Riches K, Wood I, Turner N, Porter K. TRANSFORMING GROWTH FACTOR BETA DRIVES A DISTINCT DIABETES PHENOTYPE IN HUMAN SAPHENOUS VEIN SMOOTH MUSCLE CELLS VIA UPREGULATION OF MICRORNA-143/145 Heart. 100: A4.2-A4. DOI: 10.1136/heartjnl-2014-306916.11  0.037
2022 Porter K, Miles PJ, Donaldson DI. Teachers' emotions in the time of COVID: Thematic analysis of interview data reveals drivers of professional agency. Frontiers in Psychology. 13: 987690. PMID 36405201 DOI: 10.3389/fpsyg.2022.987690  0.037
2020 Shawer H, Hemmings K, Yuldasheva N, Porter K, Foster R, Cubbon R, Schneider J, Griffin K, Beech D, Bailey M. Vascular smooth muscle cell ORAI1 in vascular health and disease Atherosclerosis. 315: e31-e32. DOI: 10.1016/j.atherosclerosis.2020.10.105  0.037
2016 Birch KM, Harris E, Birk G, Lyall G, Riches K, Ferguson C, Porter KE. Moderate Versus Heavy Intensity Interval Training For Vascular Health In Post-menopausal Women: A Paradox!: 2862 Board #2 June 3, 1: 00 PM - 3: 00 PM. Medicine and Science in Sports and Exercise. 48: 800. PMID 27584473 DOI: 10.1249/01.mss.0000487397.16238.ba  0.037
2016 Viswambharan H, Yuldasheva NY, Sengupta A, Imrie H, Gage MC, Haywood NJ, Walker AM, Skromna A, Makova N, Galloway SL, Shah P, Sukumar P, Porter KE, Grant PJ, Shah AM, et al. Selective Enhancement of Insulin Sensitivity in the Endothelium In Vivo Reveals a Novel Proatherosclerotic Signalling Loop. Circulation Research. PMID 27920123 DOI: 10.1161/CIRCRESAHA.116.309678  0.036
2013 Amer MS, McKeown L, Tumova S, Liu R, Seymour VA, Wilson LA, Naylor J, Greenhalgh K, Hou B, Majeed Y, Turner P, Sedo A, O'Regan DJ, Li J, Bon RS, ... Porter KE, et al. Inhibition of endothelial cell Ca²⁺ entry and transient receptor potential channels by Sigma-1 receptor ligands. British Journal of Pharmacology. 168: 1445-55. PMID 23121507 DOI: 10.1111/Bph.12041  0.035
2008 Patel A, Jagadesham VP, Porter KE, Scott DJ, Carding SR. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 36: 20-7. PMID 18296082 DOI: 10.1016/j.ejvs.2008.01.014  0.035
2010 Naylor J, Li J, Zeng F, Sukumar P, Majeed Y, Milligan CJ, Kumar B, Porter KE, Beech D. TRPM3 Expression and Function in Vascular Smooth Muscle Biophysical Journal. 98: 341a. DOI: 10.1016/j.bpj.2009.12.1848  0.035
2015 Li J, Bruns AF, Hou B, Rode B, Webster PJ, Bailey MA, Appleby HL, Moss NK, Ritchie JE, Yuldasheva NY, Tumova S, Quinney M, Mckeown L, Taylor H, Prasad KR, ... ... Porter KE, et al. Orai3 surface accumulation and calcium entry evoked by vascular endothelial growth factor Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 1987-1994. DOI: 10.1161/ATVBAHA.115.305969  0.033
2019 Clark ER, Porter KE, Bryant MG. Fretting-corrosion of cardiovascular stent materials: The role of electrochemical polarisation on debris generation mechanisms Biotribology. 18: 100093. DOI: 10.1016/J.BIOTRI.2019.100093  0.031
2010 Rajwani A, Surr J, Porter KE, Viswambharan H, Imrie H, Abbas A, Cubbon R, Ezzat V, Kearney MT, Wheatcroft SB. E IGFBP-1 upregulates vascular nitric oxide via PI-3-K activation and rescues endothelial function in murine models of insulin resistance: Abstract E Table 1 Heart. 96: A3-A3. DOI: 10.1136/hrt.2010.196113.18  0.028
2013 Aziz A, Yuldasheva N, Smith J, Haywood N, Paul C, Cubbon R, Kearney M, Porter K, Wheatcroft S. 166 ENHANCING VASCULAR ENDOTHELIAL REPAIR IN THE SETTING OF INSULIN RESISTANCE: EFFECTS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 Heart. 99: A96-A97. DOI: 10.1136/heartjnl-2013-304019.166  0.024
2010 Shantikumar S, Ajjan R, Porter KE, Scott DJ. Diabetes and the abdominal aortic aneurysm. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 39: 200-7. PMID 19948418 DOI: 10.1016/j.ejvs.2009.10.014  0.022
2014 Aziz A, Yuldasheva N, Smith J, Riches K, Gage M, Mughal R, Mercer BN, Sengupta A, Ali N, Cordell P, Haywood N, Cubbon RM, Kearney MT, Porter KE, Wheatcroft SB. 217 Insulin-like Growth Factor Binding Protein-1 Enhances Vascular Endothelial Repair in the Setting of Insulin Resistance Heart. 100: A118.2-A119. DOI: 10.1136/heartjnl-2014-306118.217  0.019
2007 Eccles KA, Homer‐Vanniasinkham S, Porter K, Graham A. Investigation of the potential anti‐inflammatory properties of Simvastatin The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a179-b  0.016
2018 Porter K, Warburton KG. Physicians' views on current legislation around euthanasia and assisted suicide: Results of surveys commissioned by the Royal College of Physicians. Future Healthcare Journal. 5: 30-34. PMID 31098528 DOI: 10.7861/futurehosp.5-1-30  0.014
Hide low-probability matches.